Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion

Author:

Kurozumi Kazuhiko1ORCID,Fujii Kentaro2,Washio Kana3,Ishida Joji2,Otani Yoshihiro2,Sudo Tamotsu4,Tahara Makoto5ORCID,Ichimura Koichi67,Ennishi Daisuke8,Date Isao2

Affiliation:

1. Department of Neurosurgery, Hamamatsu University School of Medicine , Shizuoka , Japan

2. Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan

3. Department of Pediatrics, Okayama University Hospital , Okayama , Japan

4. Section of Translational Research, Hyogo Cancer Center , Akashi , Japan

5. Department of Head and Neck Medical Oncology, National Cancer Center Hospital East , Kashiwa, Chiba , Japan

6. Division of Brain Tumor Translational Research, National Cancer Center Research Institute , Tokyo , Japan

7. Department of Brain Disease Translational Research, Graduate School of Medicine, Juntendo University , Tokyo , Japan

8. Center for Comprehensive Genomic Medicine, Okayama University Hospital , Okayama , Japan

Funder

Japanese Ministry of Education, Culture, Sports, Science and Technology

Publisher

Oxford University Press (OUP)

Subject

Electrical and Electronic Engineering,Building and Construction

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3